174 related articles for article (PubMed ID: 34785776)
1. MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis.
Shin Y; Kim S; Ghate NB; Rhie SK; An W
Oncogene; 2022 Jan; 41(4):560-570. PubMed ID: 34785776
[TBL] [Abstract][Full Text] [Related]
2. MMP-9 facilitates selective proteolysis of the histone H3 tail at genes necessary for proficient osteoclastogenesis.
Kim K; Punj V; Kim JM; Lee S; Ulmer TS; Lu W; Rice JC; An W
Genes Dev; 2016 Jan; 30(2):208-19. PubMed ID: 26744418
[TBL] [Abstract][Full Text] [Related]
3. The MMP-2 histone H3 N-terminal tail protease is selectively targeted to the transcription start sites of active genes.
Weekley BH; Rice JC
Epigenetics Chromatin; 2023 May; 16(1):16. PubMed ID: 37161413
[TBL] [Abstract][Full Text] [Related]
4. MMP-9-dependent proteolysis of the histone H3 N-terminal tail: a critical epigenetic step in driving oncogenic transcription and colon tumorigenesis.
Shin Y; Kim S; Liang G; An W
Mol Oncol; 2024 Apr; ():. PubMed ID: 38600695
[TBL] [Abstract][Full Text] [Related]
5. H3K27me1 is essential for MMP-9-dependent H3N-terminal tail proteolysis during osteoclastogenesis.
Kim K; Shin Y; Kim J; Ulmer TS; An W
Epigenetics Chromatin; 2018 May; 11(1):23. PubMed ID: 29807539
[TBL] [Abstract][Full Text] [Related]
6. MMP-2 is a novel histone H3 N-terminal protease necessary for myogenic gene activation.
Rice JC; Weekley BH; Kanholm T; Chen Z; Lee S; Fernandez DJ; Abrahamson R; Castaldi A; Borok Z; Dynlacht BD; An W
Epigenetics Chromatin; 2021 May; 14(1):23. PubMed ID: 34001241
[TBL] [Abstract][Full Text] [Related]
7. DNMT and HDAC inhibitors modulate MMP-9-dependent H3 N-terminal tail proteolysis and osteoclastogenesis.
Shin Y; Ghate NB; Moon B; Park K; Lu W; An W
Epigenetics Chromatin; 2019 Apr; 12(1):25. PubMed ID: 30992059
[TBL] [Abstract][Full Text] [Related]
8. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT
Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801
[TBL] [Abstract][Full Text] [Related]
9. Vitamin A upregulates matrix metalloproteinase-9 activity by murine myeloid dendritic cells through a nonclassical transcriptional mechanism.
Lackey DE; Hoag KA
J Nutr; 2010 Aug; 140(8):1502-8. PubMed ID: 20534877
[TBL] [Abstract][Full Text] [Related]
10. The role of p300 histone acetyltransferase in UV-induced histone modifications and MMP-1 gene transcription.
Kim MK; Shin JM; Eun HC; Chung JH
PLoS One; 2009; 4(3):e4864. PubMed ID: 19287485
[TBL] [Abstract][Full Text] [Related]
11. Tetracycline Analogs Inhibit Osteoclast Differentiation by Suppressing MMP-9-Mediated Histone H3 Cleavage.
Kim Y; Kim J; Lee H; Shin WR; Lee S; Lee J; Park JI; Jhun BH; Kim YH; Yi SJ; Kim K
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430857
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium avium-induced matrix metalloproteinase-9 expression occurs in a cyclooxygenase-2-dependent manner and involves phosphorylation- and acetylation-dependent chromatin modification.
Basu S; Pathak S; Pathak SK; Bhattacharyya A; Banerjee A; Kundu M; Basu J
Cell Microbiol; 2007 Dec; 9(12):2804-16. PubMed ID: 17590163
[TBL] [Abstract][Full Text] [Related]
13. Runx2 recruits p300 to mediate parathyroid hormone's effects on histone acetylation and transcriptional activation of the matrix metalloproteinase-13 gene.
Boumah CE; Lee M; Selvamurugan N; Shimizu E; Partridge NC
Mol Endocrinol; 2009 Aug; 23(8):1255-63. PubMed ID: 19423655
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma-activated STAT-1alpha suppresses MMP-9 gene transcription by sequestration of the coactivators CBP/p300.
Ma Z; Chang MJ; Shah RC; Benveniste EN
J Leukoc Biol; 2005 Aug; 78(2):515-23. PubMed ID: 15894584
[TBL] [Abstract][Full Text] [Related]
15. VprBP/DCAF1 triggers melanomagenic gene silencing through histone H2A phosphorylation.
Shin Y; Kim S; Liang G; Ulmer TS; An W
Res Sq; 2023 Jul; ():. PubMed ID: 37293029
[TBL] [Abstract][Full Text] [Related]
16. VprBP/DCAF1 Triggers Melanomagenic Gene Silencing through Histone H2A Phosphorylation.
Shin Y; Kim S; Liang G; Ulmer TS; An W
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760992
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
Bandyopadhyay D; Okan NA; Bales E; Nascimento L; Cole PA; Medrano EE
Cancer Res; 2002 Nov; 62(21):6231-9. PubMed ID: 12414652
[TBL] [Abstract][Full Text] [Related]
18. Differences in specificity and selectivity between CBP and p300 acetylation of histone H3 and H3/H4.
Henry RA; Kuo YM; Andrews AJ
Biochemistry; 2013 Aug; 52(34):5746-59. PubMed ID: 23862699
[TBL] [Abstract][Full Text] [Related]
19. Promoter-specific changes in initiation, elongation, and homeostasis of histone H3 acetylation during CBP/p300 inhibition.
Hsu E; Zemke NR; Berk AJ
Elife; 2021 Mar; 10():. PubMed ID: 33704060
[TBL] [Abstract][Full Text] [Related]
20. Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP.
Crump NT; Hazzalin CA; Bowers EM; Alani RM; Cole PA; Mahadevan LC
Proc Natl Acad Sci U S A; 2011 May; 108(19):7814-9. PubMed ID: 21518915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
